Prejuvenation and subtle treatment choices
Prejuvenation describes an interest in acting before visible ageing becomes prominent. It is a broad idea, not a single procedure or an age at which everyone should begin treatment.
Begin with a demonstrated concern
Daily sun protection has randomized evidence for slowing photoaging. Optional procedures should respond to an individual concern and realistic goals. Being in your twenties or following a trend is not, by itself, a clinical indication. Waiting or having no procedure should remain part of the discussion.
What subtle dosing actually means
Baby toxin, sprinkles and quiet-luxury tweakments describe an aesthetic approach rather than a standardized medicine or protocol. Botulinum toxin outcomes depend on the exact formulation, anatomy, dose and placement. Smaller doses do not guarantee preserved expression, remove injection risks or establish a lifelong preventive effect.
Agree on a result and a review
Explain which expressions you want to retain and which change you hope to see. Ask how the clinician will assess the settled result, whether maintenance is necessary and what would justify stopping. An understated goal can support a measured consultation; it should not make the procedure or its uncertainties disappear from view.
“What current concern are we treating and what evidence supports starting now rather than waiting?”
Read the original sources
Professional & regulatory sources
ASPS: preventative botulinum toxin and individual treatment needs (2026)Published research
Hughes et al.: randomized sunscreen and photoaging trial (2013)General education. Your clinician can assess your individual suitability. Rules depend on the treatment country; FDA references concern the United States. External sources may be in another language.